Digital Engineering 24/7

Helping design and engineering professionals discover, evaluate and specify technologies and processes that shorten the design cycle and enable success.

Cornell University Bioprints a Functional Ear

Cornell University Bioprints a Functional Ear
Dr. Bonassar displays a bioprinted ear. Courtesy of Lindsay France/Cornell University Photography.

Latest Design News

Latest Design Resources

By John Newman  

February 22, 2013

When William Shakespeare put the words, “Friends, Romans, countrymen, lend me your ears” in the mouth of Mark Anthony, he may well have been prophesizing the future. Additive manufacturing (AM) has been a natural fit for prosthetic development and manufacturing, and now Cornell University and the Weill Cornell Medical College have taken prosthetics research to a whole new level with a bioprinted ear.

While every prosthesis is designed to be functional (and some to have artistic merit), they are artificial replacements for living material. Not so with the ear developed by Dr. Jason Spector and Dr. Lawrence J. Bonassar. The bioprinting process uses living material to create a structure that remains alive after being implanted and becomes another functional biological part of the human body.

Cornell University's 3D Printed Ear

"This is such a win-win for both medicine and basic science, demonstrating what we can achieve when we work together," said Dr. Bonassar, associate professor and associate chair of the Department of Biomedical Engineering at Cornell University.

The research performed by Spector and Bonassar is meant to combat microtia, “… a congenital deformity in which the external ear is not fully developed.” Around four children out of every 10,000 are born with the condition, which usually only effects a single ear. Many times, the inner ear is fully formed, but the outer ear is deformed or missing altogether.

The bioprinting process begins with a 3D scan of an intact ear, to generate a 3D printed mold. Researchers then add animal-derived collagen into the mold, and top it off with nearly 250 million cartilage cells. The collagen acts like a scaffold for the cartilage, directing its growth. Since cartilage doesn’t require a blood supply to survive, the process manages to bypass the need for vascularization, which has yet to be perfected with AM.

"The process is fast," said Dr. Bonassar. "It takes half a day to design the mold, a day or so to print it, 30 minutes to inject the gel and we can remove the ear 15 minutes later. We trim the ear and then let it culture for several days in a nourishing cell culture medium before it is implanted."

From there, the cartilage is given three months to fully grow, slowly replacing the collagen.

"Eventually the bioengineered ear contains only auricular cartilage, just like a real ear," added Dr. Spector.

Once an ear has reached full development, it can be implanted into a patient. Spector and Bonassar say than the best time for implanting the new ear is when a patient is around five or six years old.

"We don't know yet if the bioengineered ears would continue to grow to their full size, but I suspect they will," said Dr. Spector. "Surgery to attach the new ear would be straightforward -- the malformed ear would be removed and the bioengineered ear would be inserted under a flap of skin at the site."

The research team intends to have fully developed the process in the next three years. If the project proves to be successful, it’s just the beginning of what could be possible for bioprinting.

Below you’ll find a video about the process.


Source: Weill Cornell Medical College

 
 

From our Sponsors

Meltio Takes Metal Additive to the Next Level
Meltio's DED technology enables industries to tailor and customize their solutions to create & repair metal parts.
Easing the Transition from ETO to CTO with Configuration Lifecycle Management
Manufacturers are discovering that the Configure-to-Order (CTO) model provides significant benefits when it comes to customization.
Siemens + Altair = The Next Chapter in Design and Simulation
With its acquisition of Altair, Siemens creates a unified simulation portfolio combining generative design with high-performance computing and AI workflows.